Published in Genet Med on March 14, 2013
Internet-Based Direct-to-Consumer Genetic Testing: A Systematic Review. J Med Internet Res (2015) 0.81
Information-seeking and sharing behavior following genomic testing for diabetes risk. J Genet Couns (2014) 0.78
Sequence and analysis of a whole genome from Kuwaiti population subgroup of Persian ancestry. BMC Genomics (2015) 0.77
The Application of Genomics in Diabetes: Barriers to Discovery and Implementation. Diabetes Care (2016) 0.75
Measuring inconsistency in meta-analyses. BMJ (2003) 128.20
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med (2002) 101.79
Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med (2008) 57.29
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science (2007) 51.70
Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet (2008) 35.06
Standards of medical care in diabetes--2012. Diabetes Care (2012) 20.66
New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89
Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet (2010) 16.96
Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med (2008) 9.68
Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Engl J Med (2008) 8.70
Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation (2009) 8.11
TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med (2006) 7.75
The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative: methods of the EGAPP Working Group. Genet Med (2009) 5.69
A navigator for human genome epidemiology. Nat Genet (2008) 5.07
Genotyping errors: causes, consequences and solutions. Nat Rev Genet (2005) 5.00
Assessment of cumulative evidence on genetic associations: interim guidelines. Int J Epidemiol (2007) 4.96
Consistent association of type 2 diabetes risk variants found in europeans in diverse racial and ethnic groups. PLoS Genet (2010) 3.27
Family history of diabetes as a potential public health tool. Am J Prev Med (2003) 2.76
Utility of genetic and non-genetic risk factors in prediction of type 2 diabetes: Whitehall II prospective cohort study. BMJ (2010) 2.53
SNP genotyping: technologies and biomedical applications. Annu Rev Biomed Eng (2007) 2.52
Evaluation of risk prediction updates from commercial genome-wide scans. Genet Med (2009) 2.30
Improvement of risk prediction by genomic profiling: reclassification measures versus the area under the receiver operating characteristic curve. Am J Epidemiol (2010) 2.06
Genetic risk reclassification for type 2 diabetes by age below or above 50 years using 40 type 2 diabetes risk single nucleotide polymorphisms. Diabetes Care (2010) 2.06
Common variants in 40 genes assessed for diabetes incidence and response to metformin and lifestyle intervention in the diabetes prevention program. Diabetes (2010) 2.02
Variants of transcription factor 7-like 2 (TCF7L2) gene predict conversion to type 2 diabetes in the Finnish Diabetes Prevention Study and are associated with impaired glucose regulation and impaired insulin secretion. Diabetologia (2007) 1.97
Genotyping technologies for genetic research. Annu Rev Genomics Hum Genet (2009) 1.78
Extension of type 2 diabetes genome-wide association scan results in the diabetes prevention program. Diabetes (2008) 1.71
Type 2 diabetes-associated missense polymorphisms KCNJ11 E23K and ABCC8 A1369S influence progression to diabetes and response to interventions in the Diabetes Prevention Program. Diabetes (2007) 1.51
Effects of the type 2 diabetes-associated PPARG P12A polymorphism on progression to diabetes and response to troglitazone. J Clin Endocrinol Metab (2007) 1.49
Horizon scanning for new genomic tests. Genet Med (2011) 1.36
Whole-grain consumption and transcription factor-7-like 2 ( TCF7L2) rs7903146: gene-diet interaction in modulating type 2 diabetes risk. Br J Nutr (2008) 1.35
Detecting undiagnosed type 2 diabetes: family history as a risk factor and screening tool. J Diabetes Sci Technol (2009) 1.19
The Georgia Cardiovascular Twin Study: influence of genetic predisposition and chronic stress on risk for cardiovascular disease and type 2 diabetes. Twin Res Hum Genet (2006) 1.16
Impact of laparoscopic adjustable gastric banding on type 2 diabetes. Obes Rev (2011) 1.01
Serum magnesium and type-2 diabetes in African Americans and Hispanics: a New York cohort. J Am Coll Nutr (2006) 0.98
Postmarketing surveillance of acarbose treatment in Taiwanese patients with type 2 diabetes mellitus. Clin Drug Investig (2006) 0.96
Use of genomic profiling to assess risk for cardiovascular disease and identify individualized prevention strategies--a targeted evidence-based review. Genet Med (2010) 0.89
TCF7L2 rs7903146-macronutrient interaction in obese individuals' responses to a 10-wk randomized hypoenergetic diet. Am J Clin Nutr (2009) 0.88
Identification and treatment of prediabetes to prevent progression to type 2 diabetes. Clin Cornerstone (2007) 0.87
Five genetic variants associated with prostate cancer. N Engl J Med (2008) 0.87
TCF7L2 expression in diabetic patients undergoing bariatric surgery. Surg Endosc (2008) 0.84
Identification and treatment of prediabetes to prevent progression to type 2 diabetes. Clin Cornerstone (2008) 0.84
HuGE Watch: tracking trends and patterns of published studies of genetic association and human genome epidemiology in near-real time. Eur J Hum Genet (2008) 0.82
[A case report of simultaneous liver, pancreas-duodenum, and kidney transplantation in a patient with post-hepatitic cirrhosis combined with uremia and insulin-dependent diabetes related to chronic pancreatitis]. Zhonghua Yi Xue Za Zhi (2006) 0.76
The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative: methods of the EGAPP Working Group. Genet Med (2009) 5.69
Effectiveness of interventions to increase screening for breast, cervical, and colorectal cancers: nine updated systematic reviews for the guide to community preventive services. Am J Prev Med (2012) 4.07
EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome. Genet Med (2009) 3.57
Client-directed interventions to increase community demand for breast, cervical, and colorectal cancer screening a systematic review. Am J Prev Med (2008) 3.05
Blood pressure control for diabetic retinopathy. Cochrane Database Syst Rev (2015) 2.19
Intervention to increase recommendation and delivery of screening for breast, cervical, and colorectal cancers by healthcare providers a systematic review of provider reminders. Am J Prev Med (2010) 2.12
Client-directed interventions to increase community access to breast, cervical, and colorectal cancer screening a systematic review. Am J Prev Med (2008) 2.01
Association between 9p21 genomic markers and heart disease: a meta-analysis. JAMA (2010) 1.71
Taxonomic variation in the Mycobacterium fortuitum third biovariant complex: description of Mycobacterium boenickei sp. nov., Mycobacterium houstonense sp. nov., Mycobacterium neworleansense sp. nov. and Mycobacterium brisbanense sp. nov. and recognition of Mycobacterium porcinum from human clinical isolates. Int J Syst Evol Microbiol (2004) 1.51
Can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan? An evidence-based review. Genet Med (2009) 1.49
Strengthening the reporting of Genetic RIsk Prediction Studies (GRIPS): explanation and elaboration. J Clin Epidemiol (2011) 1.46
Blood pressure control for diabetic retinopathy. Sao Paulo Med J (2015) 1.40
Horizon scanning for new genomic tests. Genet Med (2011) 1.36
Improving the efficiency and relevance of evidence-based recommendations in the era of whole-genome sequencing: an EGAPP methods update. Genet Med (2012) 1.34
Paracoccus yeeii sp. nov. (formerly CDC group EO-2), a novel bacterial species associated with human infection. J Clin Microbiol (2003) 1.29
Fecal DNA testing for Colorectal Cancer Screening: the ColoSure™ test. PLoS Curr (2011) 1.02
Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration. Eur J Epidemiol (2011) 0.94
Use of genomic profiling to assess risk for cardiovascular disease and identify individualized prevention strategies--a targeted evidence-based review. Genet Med (2010) 0.89
Genetic testing for lynch syndrome in individuals newly diagnosed with colorectal cancer to reduce morbidity and mortality from colorectal cancer in their relatives. PLoS Curr (2011) 0.88
Autologous serum eye drops for dry eye. Cochrane Database Syst Rev (2013) 0.88
Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration. Eur J Clin Invest (2011) 0.85
Identifying promising practices for evaluation: the National Breast and Cervical Cancer Early Detection Program. Cancer Causes Control (2015) 0.85
Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration. Eur J Hum Genet (2011) 0.79
Short and longer-term effects of creatine supplementation on exercise induced muscle damage. J Sports Sci Med (2009) 0.77
Using Evidence-Based Interventions to Improve Cancer Screening in the National Breast and Cervical Cancer Early Detection Program. J Public Health Manag Pract (2016) 0.75